{"url_path":"/sec/insm/8-k/2026-07-16/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 —","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-16","source_url":"https://www.sec.gov/Archives/edgar/data/1104506/0001140361-26-028602-index.html","accession_number":"0001140361-26-028602","cik":"0001104506","ticker":"INSM","issuer_name":"INSMED Inc","edgar_url":"https://www.sec.gov/Archives/edgar/data/1104506/0001140361-26-028602-index.html","primary_entity_key":"0001104506","primary_entity_name":"INSMED Inc"},"word_count":98,"has_tables":true,"body_markdown":"ITEM 9.01  —\n\nFinancial Statements and Exhibits.\n\n(d) Exhibits\n\nExhibit\n\nNo.\n\n \n\nDescription\n\n \n\n \n\n \n\n[99.1](ef20078093_ex99-1.htm)\n\n \n\nPress release issued by Insmed Incorporated on July 16, 2026.\n\n[99.2](ef20078093_ex99-2.htm)\n\n \n\nInsmed Incorporated July 16, 2026 12-Month OLE Study Presentation\n\n104\n\n \n\nCover Page Interactive Date File (embedded within the Inline XBRL document).\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the\nundersigned hereunto duly authorized.\n\nDated: July 16, 2026\n\nINSMED INCORPORATED\n\n \n\n \n\n \n\nBy:\n\n/s/ Michael A. Smith\n\n \n\nName:\n\nMichael A. Smith\n\n \n\nTitle:\n\nChief Legal Officer and Corporate Secretary"}